Literature DB >> 23749591

Attitudes towards cross-border reproductive care among infertile Japanese patients.

Yuri Hibino1, Yosuke Shimazono, Yasuhiro Kambayashi, Yoshiaki Hitomi, Hiroyuki Nakamura.   

Abstract

OBJECTIVES: The attitudes towards cross-border reproductive care (CBRC) held by infertile Japanese patients have not been explored. The objective of the present study was to examine interest levels, preferred destinations, motivations, and sources of information related to CBRC. Our findings provide a general outline of CBRC and the future of reproduction and assisted reproductive technology (ART) in Japan.
METHODS: The study used a cross-sectional design. Data were collected from 2,007 infertile Japanese patients from 65 accredited ART clinics in Japan (response rate, 27.4 %) via anonymous questionnaires.
RESULTS: Most of the infertile Japanese patients who responded denied using CBRC. However, by group, 171 (8.5 %) patients in non-donor in vitro fertilization, 150 (7.5 %) in egg donation, 145 (7.2 %) in pre-implantation genetic diagnosis, and 129 (6.4 %) in surrogacy said that, depending on the situation, they might travel abroad in the future. Older respondents were more likely to express an intention to travel overseas for egg donation in the future. The most popular destination for CBRC was the United States. Popular reasons for interest in CBRC among those considering or planning using this approach to third-party reproduction were that egg donation or surrogacy was unavailable or that obtaining ethical approval takes too long in Japan, whereas these processes are legal and affordable overseas. However, high cost was the most common reason for hesitancy regarding CBRC. Among the participants who were considering or planning to travel abroad for this purpose, TV, medical agencies, print media, and message boards on websites were popular sources of information, whereas doctors, friends, and patient self-help groups were not.
CONCLUSIONS: Although CBRC among infertile Japanese patients is not at present common, the demand for and use of this approach may increase in the future in the context of the increasingly aging population. Lack of regulation and unavailability of third-party reproduction is a major cause of CBRC among Japanese patients. Health care provider faces an urgent need for giving useful information for patients regarding CBRC.

Entities:  

Mesh:

Year:  2013        PMID: 23749591      PMCID: PMC3824726          DOI: 10.1007/s12199-013-0345-7

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  15 in total

1.  Cross-border reproductive care: a phenomenon expressing the controversial aspects of reproductive technologies.

Authors:  Anna Pia Ferraretti; Guido Pennings; Luca Gianaroli; Francesca Natali; M Cristina Magli
Journal:  Reprod Biomed Online       Date:  2009-11-26       Impact factor: 3.828

2.  Legal harmonization and reproductive tourism in Europe.

Authors:  Guido Pennings
Journal:  Hum Reprod       Date:  2004-10-28       Impact factor: 6.918

3.  The impact of cross-border reproductive care or 'fertility tourism' on NHS maternity services.

Authors:  A McKelvey; A L David; F Shenfield; E R Jauniaux
Journal:  BJOG       Date:  2009-07-15       Impact factor: 6.531

4.  Cross border reproductive care in six European countries.

Authors:  F Shenfield; J de Mouzon; G Pennings; A P Ferraretti; A Nyboe Andersen; G de Wert; V Goossens
Journal:  Hum Reprod       Date:  2010-03-26       Impact factor: 6.918

5.  Cross-border fertility services in North America: a survey of Canadian and American providers.

Authors:  Edward G Hughes; Deirdre Dejean
Journal:  Fertil Steril       Date:  2010-02-11       Impact factor: 7.329

6.  Fertility patients' experiences of cross-border reproductive care.

Authors:  Eric Blyth
Journal:  Fertil Steril       Date:  2010-03-06       Impact factor: 7.329

7.  Crossing borders for fertility treatment: motivations, destinations and outcomes of UK fertility travellers.

Authors:  L Culley; N Hudson; F Rapport; E Blyth; W Norton; A A Pacey
Journal:  Hum Reprod       Date:  2011-06-29       Impact factor: 6.918

8.  Cross-border fertility care--International Committee Monitoring Assisted Reproductive Technologies global survey: 2006 data and estimates.

Authors:  Karl Nygren; David Adamson; Fernando Zegers-Hochschild; Jacques de Mouzon
Journal:  Fertil Steril       Date:  2010-02-13       Impact factor: 7.329

9.  Rethinking reproductive "tourism" as reproductive "exile".

Authors:  Marcia C Inhorn; Pasquale Patrizio
Journal:  Fertil Steril       Date:  2009-02-26       Impact factor: 7.329

10.  Cross-border reproductive care in Belgium.

Authors:  G Pennings; C Autin; W Decleer; A Delbaere; L Delbeke; A Delvigne; D De Neubourg; P Devroey; M Dhont; T D'Hooghe; S Gordts; B Lejeune; M Nijs; P Pauwels; B Perrad; C Pirard; F Vandekerckhove
Journal:  Hum Reprod       Date:  2009-09-02       Impact factor: 6.918

View more
  3 in total

Review 1.  Cross border reproductive care (CBRC): a growing global phenomenon with multidimensional implications (a systematic and critical review).

Authors:  Mahmoud Salama; Vladimir Isachenko; Evgenia Isachenko; Gohar Rahimi; Peter Mallmann; Lynn M Westphal; Marcia C Inhorn; Pasquale Patrizio
Journal:  J Assist Reprod Genet       Date:  2018-05-28       Impact factor: 3.412

2.  Survey of Attitudes toward Uterus Transplantation among Japanese Women of Reproductive Age: A Cross-Sectional Study.

Authors:  Iori Kisu; Kouji Banno; Etsuko Soeda; Yuki Kurihara; Miho Okushima; Ami Yamaguchi; Eriko Nakagawa; Kiyoko Umene; Daisuke Aoki
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

3.  A survey of public attitudes towards third-party reproduction in Japan in 2014.

Authors:  Naoko Yamamoto; Tetsuya Hirata; Gentaro Izumi; Akari Nakazawa; Shinya Fukuda; Kazuaki Neriishi; Tomoko Arakawa; Masashi Takamura; Miyuki Harada; Yasushi Hirota; Kaori Koga; Osamu Wada-Hiraike; Tomoyuki Fujii; Minoru Irahara; Yutaka Osuga
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.